209 related articles for article (PubMed ID: 10835711)
41. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
[TBL] [Abstract][Full Text] [Related]
42. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy.
Eckman MH; Levine HJ; Pauker SG
N Engl J Med; 1993 Sep; 329(10):696-702. PubMed ID: 8135917
[TBL] [Abstract][Full Text] [Related]
43. [Hemorrhagic complications during warfarin treatment].
Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
[TBL] [Abstract][Full Text] [Related]
44. Antithrombotic therapies for stroke prevention in atrial fibrillation.
Economides Muñoz C; Singh BN
Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
[TBL] [Abstract][Full Text] [Related]
45. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
46. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
47. Improvement of oral anticoagulation therapy by INR self-management.
Horstkotte D; Piper C
J Heart Valve Dis; 2004 May; 13(3):335-8. PubMed ID: 15222277
[TBL] [Abstract][Full Text] [Related]
48. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
49. Control of oral anticoagulant therapy.
Biemer JJ
Ann Clin Lab Sci; 1988; 18(6):421-8. PubMed ID: 3239946
[TBL] [Abstract][Full Text] [Related]
50. Improved therapeutic safety of oral anticoagulant therapy in Germany: the Saarland model.
Mörsdorf S; Leipnitz G; Pindur G; Schenk JF; Erdlenbruch W; Krischek B; Wenzel E
Semin Thromb Hemost; 1999; 25(1):49-55. PubMed ID: 10327221
[TBL] [Abstract][Full Text] [Related]
51. Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodology.
Barbui T; Finazzi G; Remuzzi A
Thromb Haemost; 1995 Jul; 74(1):511-4. PubMed ID: 8578515
[TBL] [Abstract][Full Text] [Related]
52. [Introduction of acenocoumarol using an algorithm for prescription].
Notaridis G; Gschwind L; de Moerloose P; Boehlen F
Rev Med Suisse; 2010 Feb; 6(235):292, 294-7. PubMed ID: 20218178
[TBL] [Abstract][Full Text] [Related]
53. [How can we improve long-term anticoagulation?].
Beck EA
Schweiz Med Wochenschr; 1985 Oct; 115(43):1495-500. PubMed ID: 4081678
[TBL] [Abstract][Full Text] [Related]
54. [Prevention of venous thromboses with oral anticoagulants].
Hach-Wunderle V; Scharrer I
Wien Med Wochenschr; 1989 Dec; 139(23):559-62. PubMed ID: 2696215
[TBL] [Abstract][Full Text] [Related]
55. Problems of the laboratory control of oral anticoagulant treatment.
Hummel L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):529-31. PubMed ID: 2465967
[TBL] [Abstract][Full Text] [Related]
56. Computer-aided dosage in oral anticoagulation therapy using phenprocoumon. Problems and approaches.
Cromme L; Völler H; Gäbler F; Salzwedel A; Taborski U
Hamostaseologie; 2010 Nov; 30(4):183-9. PubMed ID: 21057712
[TBL] [Abstract][Full Text] [Related]
57. The pharmacology of oral anticoagulants: implications for therapy.
Shetty HG; Woods F; Routledge PA
J Heart Valve Dis; 1993 Jan; 2(1):53-62. PubMed ID: 8269110
[TBL] [Abstract][Full Text] [Related]
58. Oral anticoagulant therapy--50 years later.
Ansell JE
Arch Intern Med; 1993 Mar; 153(5):586-96. PubMed ID: 8439222
[TBL] [Abstract][Full Text] [Related]
59. A review of variables affecting PTs/INRs.
McGlasson DL
Clin Lab Sci; 1999; 12(6):353-8. PubMed ID: 10724633
[TBL] [Abstract][Full Text] [Related]
60. Sample carryover in PT-INR determination is it an issue in Oral Anticoagulant Therapy control?
Corno AR; Redaelli R; Caimi TM; Mostarda G; Caruso R; Morra E
Thromb Res; 2011 Mar; 127(3):279-81. PubMed ID: 21129767
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
